Glenmark Pharmaceuticals receives ANDA approval for Fulvestrant Injection General Announcement Filing viewer · member access Original SGX announcement
Intimation of the date of 41st Annual General Meeting and Book Closure General Announcement Filing viewer · member access Original SGX announcement
First Quarter Results Financial Statements and Related Announcement Filing viewer · member access Original SGX announcement
Glenmark & Torrent sign licensing agreement for co-marketing of Remogliflozin Etabonate in India General Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceuticals receives ANDA approval for Ezetimibe and Simvastatin Tablets General Announcement Filing viewer · member access Original SGX announcement
Full Yearly Results Financial Statements and Related Announcement Filing viewer · member access Original SGX announcement
GPL receives ANDA approval for Aspirin and Extended-Release Dipyridamole Capsules General Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceuticals receives ANDA approval for Solifenacin Succinate Tablets General Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceuticals receives ANDA approval for Esomeprazole Magnesium Delayed-Release Capsules General Announcement Filing viewer · member access Original SGX announcement
Intimation of Board Meeting General Announcement Filing viewer · member access Original SGX announcement
Glenmark Therapeutics Expands Specialty Portfolio with OTIPRIO Co Promotion Agreement in the U.S. General Announcement Filing viewer · member access Original SGX announcement
Glenmark launches novel, globally-researched anti-diabetes drug Remogliflozin in India General Announcement Filing viewer · member access Original SGX announcement
Approval from Russian Ministry Healthcare to market Momate Rhino metered nasal spray as OTC product General Announcement Filing viewer · member access Original SGX announcement
GPL receives ANDA approval for Telmisartan and Hydrochlorothiazide Tablets General Announcement Filing viewer · member access Original SGX announcement
GPL Announces Results from New Analysis of Pooled Data on Ryaltris General Announcement Filing viewer · member access Original SGX announcement
Third Quarter Results Financial Statements and Related Announcement Filing viewer · member access Original SGX announcement
GPL receives ANDA approval for Clobetasol Propionate Foam,0.05% General Announcement Filing viewer · member access Original SGX announcement
GPL receives ANDA approval for Sevelamer Hydrochloride Tablets, 400 mg and 800 mg General Announcement Filing viewer · member access Original SGX announcement
GPL receives Tentative ANDA approval for Topiramate Extended-Release Capsules General Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceuticals receives tentative ANDA approval for Abiraterone Acetate Tablets USP General Announcement Filing viewer · member access Original SGX announcement
Completion of transfer of Company's Active Pharmaceuticals Ingredient (API) Business General Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceuticals Announces Entry into Branded Dermatology Segment in the United States General Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceuticals receives ANDA approval for Fluocinolone Acetonide Oil, 0.01% (Ear Drops) General Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceuticals Announces New Data on GBR 1302, a HER2xCD3 Bispecific Antibody General Announcement Filing viewer · member access Original SGX announcement